International Journal of Clinical Oncology

, Volume 23, Issue 2, pp 402–402 | Cite as

Correction to: S-1 and irinotecan plus bevacizumab as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: a multicenter phase II study in Japan (KSCC1102)

  • Yuji Miyamoto
  • Akihito Tsuji
  • Hiroaki Tanioka
  • Soichiro Maekawa
  • Hirofumi Kawanaka
  • Masaki Kitazono
  • Eiji Oki
  • Yasunori Emi
  • Hidetsugu Murakami
  • Yutaka Ogata
  • Hiroshi Saeki
  • Mototsugu Shimokawa
  • Shoji Natsugoe
  • Yoshito Akagi
  • Hideo Baba
  • Yoshihiko Maehara
Correction

Correction to: Int J Clin Oncol (2016) 21:705–712 https://doi.org/10.1007/s10147-015-0943-z

In the original publication, in Abstract, the sentence that reads as, “Oral S-1 at a dose of 80 mg/m2 was…………. drug-free interval” should read as, “Oral S-1 at a dose of 40 mg/m2 was administered twice daily for 2 weeks, followed by a 1-week drug-free interval".

In Patients and Methods, under the heading Treatment Plan, the sentence that reads as “Specifically, …………..that did not exceed 40 mg/m2 based on BSA as follows—BSA < 1.25 m2, 40 mg; BSA 1.25–1.5 m2, 50 mg twice daily; and BSA > 1.5 m2, 60 mg” should read as, “Specifically, the drug was administered orally twice daily for 14 consecutive days at a dose based on BSA as follows—BSA < 1.25 m2, 40 mg; BSA 1.25–1.5 m2, 50 mg; BSA ≥ 1.5 m2, 60 mg”.

Copyright information

© Japan Society of Clinical Oncology 2017

Authors and Affiliations

  • Yuji Miyamoto
    • 1
  • Akihito Tsuji
    • 2
  • Hiroaki Tanioka
    • 3
  • Soichiro Maekawa
    • 4
  • Hirofumi Kawanaka
    • 5
    • 6
  • Masaki Kitazono
    • 7
  • Eiji Oki
    • 8
  • Yasunori Emi
    • 9
  • Hidetsugu Murakami
    • 10
  • Yutaka Ogata
    • 11
  • Hiroshi Saeki
    • 7
  • Mototsugu Shimokawa
    • 12
  • Shoji Natsugoe
    • 13
  • Yoshito Akagi
    • 10
  • Hideo Baba
    • 1
  • Yoshihiko Maehara
    • 8
  1. 1.Department of Gastroenterological Surgery, Graduate School of Medical SciencesKumamoto UniversityKumamotoJapan
  2. 2.Department of Clinical Oncology, Faculty of MedicineKagawa UniversityKagawaJapan
  3. 3.Department of Medical OncologyOkayama Rousai HospitalOkayamaJapan
  4. 4.Department of SurgeryMunakata Medical Association HospitalFukuokaJapan
  5. 5.National Hospital OrganizationBeppu Medical CenterBeppuJapan
  6. 6.Clinical Research Institute and Department of SurgeryOitaJapan
  7. 7.Gastroenterological SurgeryNanpuh HospitalKagoshimaJapan
  8. 8.Department of Surgery and Science, Graduate School of Medical SciencesKyushu UniversityFukuokaJapan
  9. 9.Department of SurgerySaiseikai Fukuoka General HospitalFukuokaJapan
  10. 10.Department of SurgeryKurume University School of MedicineKurumeJapan
  11. 11.Department of SurgeryKurume University Medical CenterKurumeJapan
  12. 12.Department of Cancer Information ResearchNational Hospital Organization Kyushu Cancer CenterFukuokaJapan
  13. 13.Department of Digestive Surgery, Breast and Thyroid SurgeryKagoshima University Graduate School of Medical and Dental SciencesKagoshimaJapan

Personalised recommendations